University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Genetic Susceptibility TO Ozone-induced Airway Inflammation in Humans

Not Applicable

Completed

Conditions: Healthy Control

Interventions: Other: ozone

First Posted Date: 2009-02-10

Last Posted Date: 2017-09-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 84

Registration Number: NCT00840528

Locations: 🇺🇸
US EPA Human Studies Facility, Chapel Hill, North Carolina, United States

A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals

Phase 1

Completed

Conditions: Asthma
Hypersensitivity

Interventions: Biological: Clinical Center Reference Endotoxin (CCRE)

First Posted Date: 2009-02-09

Last Posted Date: 2012-12-05

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 32

Registration Number: NCT00839124

Locations: 🇺🇸
UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults

Phase 1

Completed

Conditions: Asthma
Rhinitis, Allergic, Perennial
Rhinitis, Allergic, Seasonal

First Posted Date: 2009-02-09

Last Posted Date: 2009-12-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 11

Registration Number: NCT00839189

Locations: 🇺🇸
UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Response of Airway Cells to 20,000 EU of Endotoxin in Normal Adults

Phase 1

Terminated

Conditions: Healthy Controls

Interventions: Biological: Clinical Center Reference Endotoxin (CCRE)

First Posted Date: 2009-02-09

Last Posted Date: 2012-10-08

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 26

Registration Number: NCT00838851

Locations: 🇺🇸
UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics

Phase 1

Completed

Conditions: Allergic
Asthmatic
Allergy
Asthma

Interventions: Dietary Supplement: gamma-tocopherol

First Posted Date: 2009-02-04

Last Posted Date: 2011-11-06

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 25

Registration Number: NCT00836368

Locations: 🇺🇸
Center for Environmental Medicine Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes

Phase 2

Completed

Conditions: Non Insulin Dependent Diabetes
Pregnancy

Interventions: Drug: Insulin
Drug: Metformin

First Posted Date: 2009-02-04

Last Posted Date: 2017-04-25

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 31

Registration Number: NCT00835861

Locations: 🇺🇸
University of North Carolina Hospitals Obstetric Clinics, Chapel Hill, North Carolina, United States

A Safety Study of Eptifibatide in Patients With Sickle Cell Disease

Phase 1

Terminated

Conditions: Sickle Cell Disease

Interventions: Drug: Eptifibatide
Drug: Placebo

First Posted Date: 2009-02-03

Last Posted Date: 2013-06-27

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 13

Registration Number: NCT00834899

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Comparison of Antibiotics for Pseudomonas in Early CF

Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Drug: ceftazidime and tobramycin
Drug: inhaled tobramycin

First Posted Date: 2009-01-15

Last Posted Date: 2011-04-18

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 21

Registration Number: NCT00823238

Oral Immunotherapy (OIT) for Peanut Allergy

Phase 2

Completed

Conditions: Peanut Hypersensitivity

Interventions: Drug: Peanut OIT
Drug: Placebo

First Posted Date: 2008-12-29

Last Posted Date: 2018-03-01

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 16

Registration Number: NCT00815035

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease

Recruiting

Conditions: Kartagener Syndrome

First Posted Date: 2008-12-12

Last Posted Date: 2024-08-26

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 1800

Registration Number: NCT00807482

Locations: 🇺🇸
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy